Aditya Birla Sun Life Pharma and Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹7404 Cr | ₹704 Cr |
Min Investment | ₹5000 | ₹1000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 01 Jun 2004 | 05 Jul 2019 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 31% |
Expense Ratio | 1.82 | 2.37 |
Manager | Sailesh Raj Bhan | Dhaval Joshi |
ISIN Code | INF204K01968 | INF209KB1N91 |
Exits Load | Exit load of 1% if redeemed within 1 month./365 | Exit load of 1% if redeemed within 30 days./365 |
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Month | 6.25% | 5.81% |
6 Month | 19.11% | 18.62% |
1 Year | 47.43% | 52.25% |
3 Year | 18.54% | 17.32% |
5 Year | 30.13% | 25.87% |
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
6 Month | - | - |
1 Year | 17.1% | 17.07% |
3 Year | 43.51% | 41.28% |
5 Year | 81.66% | 69.6% |
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Year | 26.16% | 22.24% |
3 Year | 53.8% | 45.6% |
5 Year | 80.65% | 68.38% |
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Standard Deviation | 14.36% | 14.83% |
Sharp | 0.68% | 0.61% |
Beta | 0.91% | 0.96% |
Alpha | 1.57% | 0.67% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts GuidanceScheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Dhaval Joshi |
Total AUM | ₹96086 Cr | ₹361932 Cr |
Fund Manage | 5 | 55 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Large Cap | 41.85 | 41.66 |
Mid Cap | 35.52 | 36.37 |
Small Cap | 20.97 | 18.68 |
Others | 1.66 | 3.28 |
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Healthcare | 98.34 | 93.86 |
Others | 1.66 | 2.25 |
Insurance | - | 1.86 |
Services | - | 1.03 |
Chemicals | - | 0.99 |
Top Comparisons
ICICI Prudential ELSS Tax Saver Fund (Tax Saving) - Growth
3Y Returns16.95%
Sundaram ELSS Tax Saver Fund Regular Growth
3Y Returns16.61%
UTI Medium Duration Fund - Regular Plan - Growth Option
3Y Returns6.03%
SUNDARAM MEDIUM DURATION FUND Regular Plan - Growth
3Y Returns3.6%
Kotak Multi Asset Allocation Fund - Regular (G)
3Y Returns0%
UTI Multi Asset Allocation Fund - Regular Plan - Growth Option
3Y Returns17.97%
Franklin India Corporate Debt Fund - Growth
3Y Returns5.23%
Axis Corporate Debt Fund - Regular Plan Growth
3Y Returns5.65%